CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management

Part of paid clinical trials in Totowa, New Jersey.

Sponsor
Hackensack Meridian Health
Study ID
NCT06804395
Status
Recruiting
Apply to this trial

Conditions

  • Cancer Risk

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will prospectively collect data from participants in the form of questionnaires. The registry will also capture data that is collected as per non-research assessments, for participants who consent to participate. The registry will facilitate better understanding of cancer risk, screening, and diagnostics.

Key Dates

Start date
Oct 1, 2024
Status verified
May 2026
Primary completion
Oct 1, 2034
Completion
Oct 1, 2034

Study Design

Enrollment
10,000 participants (estimated)

Primary Outcome Measure

Rate of Pathogenic Germline Variants (PGV) [ Time Frame: 10 years from study initiation as defined based on the date the first patient was enrolled. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Hennessy Institute for Cancer Prevention and Applied Molecular MedicineTotowaNew Jersey07462
Lee Ifhar, MSs, CCRP
[email protected]
862-657-4227

Find similar trials in Totowa, NJ

By research site
Hennessy Institute for Cancer Prevention and Applied Molecular Medicine· Totowa, NJ

Related Studies